Bibliographic Details
| Title: |
MYBL2 drives prostate cancer plasticity and identifies CDK2 as a therapeutic vulnerability in RB1-loss and neuroendocrine prostate cancer. |
| Authors: |
German B, Singh JN, Fonseca MA, Burkhart DL, Sheahan A, Bergom H, Morel KL, Beltran H, Hwang JH, Lawrenson K, Ellis L |
| Source: |
BioRxiv : the preprint server for biology [bioRxiv] 2024 Feb 02. Date of Electronic Publication: 2024 Feb 02. |
| Publication Type: |
Preprint; Journal Article |
| Journal Info: |
Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE |
| Database: |
MEDLINE Ultimate |
